INTRODUCTION Laparoscopic adjustable gastric banding is the most frequently performed bariatric procedure for the treatment of morbid obesity and is associated with low morbidity and mortality. Complications related to obesity surgery are rare and their presentation is often non-specific. Thus, it is highly important for physicians who are practising bariatric surgery to be aware of complicatio...

Obesity is an increasingly prevalent cardiovascular risk factor. It implies a hemodynamic overload, leading to functional anatomical changes in the heart, with ventricular hypertrophy and systo-diastolic dysfunction. The most effective treatment is bariatric surgery, which has a cardioprotective effect, improving ventricular geometry and function. We analyzed medium-term structural and function...

The proportion of obese individuals continues to increase worldwide. Bariatric surgery remains the only evidence-based treatment strategy to produce marked weight loss. Roux-en-Y gastric bypass is an effective and common bariatric surgical procedure offered to obese patients. However, a small percentage of individuals can develop narrowing or stricture formation of the gastrojejunal anastomosis...

BACKGROUND Obesity is an increasing disease worldwide. Bariatric surgery is the only effective therapy to induce sufficient long-term weight loss for morbidly obese patients. Laparoscopic Roux-en-Y Gastric Bypass (LRYGB) is the gold standard surgical technique. Laparoscopic Sleeve Gastrectomy (LSG) is a new promising bariatric procedure which has the advantage of maintaining an intact gastroint...

Obesity has become one of the world’s major health issues due to its endemic progression and associated comorbidities. The International Association for the Study of Obesity reported that approximately 40-50% of men and 25-35% of women in the EU were overweight (defined as a BMI between 25.0 and 29.9 kg/m2), and an additional 15-25% of men and 15-25% of women were obese (BMI ≥ 30.0 kg/m2) [1]. ...

ARIATRIC SURGERY can take weight off and keep it off, but it is not a cure, and it is not for everyone. Nevertheless, given the increasing prevalence of obesity and the limited effectiveness of diet therapy in morbidly obese people, there has been tremendous public interest in surgery for obesity. As a result, primary care physicians are encountering more patients who are contemplating or have ...

Bariatric surgery in diabetes Lee Kaplan (Boston, MA) discussed new information based on studies of bariatric surgery in diabetes. Surgery is performed in 0.25% of Americans with obesity, so it is unlikely that it in itself can address the U.S. diabetes or obesity issues, but lessons from its use may shed light on the approach to obesity and diabetes for the overall population. The biology of o...

Morbid obesity is a lifelong disease, and all patients require complementary follow-up including nutritional surveillance by a multidisciplinary team after bariatric procedures. Pancreatic exocrine insufficiency (PEI) refers to an insufficient secretion of pancreatic enzymes and/or sodium bicarbonate. PEI is a known multifactorial complication after upper gastrointestinal surgery, and might con...

Bariatric surgery is increasingly performed on overweight individuals. A significant benefit with respect to cardiovascular (CV) events and survival has been documented. After weight loss, reduction of albuminuria/proteinuria is almost consistently seen; small studies documented retardation of the glomerular filtration rate (GFR) loss after bariatric surgery; reduction of blood pressure (BP) is...

BACKGROUND Obesity is a leading health concern in the United States. Because traditional treatment approaches for weight loss are generally unsuccessful in the long term, bariatric surgical procedures are increasingly being performed to treat extreme obesity. To facilitate research in this field, the National Institute of Diabetes and Digestive and Kidney Diseases responded to this knowledge ga...